tezosentan has been researched along with Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, KR; Jo, WM; Kim, HJ; Ryu, SM | 1 |
1 other study(ies) available for tezosentan and Cardiomyopathies
| Article | Year |
|---|---|
Myocardial protective effect of tezosentan, an endothelin receptor antagonist, for ischemia-reperfusion injury in experimental heart failure models.
Topics: Animals; Cardiomyopathies; Coronary Vessels; Disease Models, Animal; Doxorubicin; Endothelin Receptor Antagonists; Heart Failure; Hypertrophy; Male; Pressure; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Endothelin; Reperfusion Injury; Tetrazoles; Vasodilator Agents; Ventricular Function, Left | 2009 |